Porcine Vaccines - Global Strategic Business Report

The global market for Porcine Vaccines was estimated at US$2.2 Billion in 2023, and is projected to reach US$3.0 Billion by 2030, growing at a CAGR of 5.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the porcine vaccines market is driven by several factors, including the increasing prevalence of swine diseases, global expansion of pork production, and heightened awareness among farmers about the benefits of vaccination. The spread of intensive pig farming and the consequent rise in disease transmission risks necessitate robust vaccination protocols. Economic growth in emerging markets has led to increased demand for pork, incentivizing producers to invest in health management practices, including vaccination, to boost yields and profitability. Furthermore, regulatory policies promoting animal health and food safety have mandated the use of vaccines in many countries, reinforcing market growth. Advances in vaccine technology, such as the development of DNA vaccines and the use of adjuvants to enhance immune responses, also play a critical role. Collectively, these drivers are shaping a vibrant market landscape, highlighting the importance of continued innovation and adaptation in vaccine development to meet the evolving challenges in swine health management.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Inactivated Vaccines Technology segment, which is expected to reach US$1.2 Billion by 2030 with a CAGR of a 5.8%. The Recombinant Vaccines Technology segment is also set to grow at 5.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $586.7 Million in 2023, and China, forecasted to grow at an impressive 8.4% CAGR to reach $634.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Porcine Vaccines Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Porcine Vaccines Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Porcine Vaccines Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Bimeda Biologicals Inc., Boehringer Ingelheim Animal Health USA Inc., Ceva Sante Animale, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 86 Featured):

• Bimeda Biologicals Inc.
• Boehringer Ingelheim Animal Health USA Inc.
• Ceva Sante Animale
• Elanco Animal Health
• Endovac Animal Health
• ICAR-Indian Veterinary Research Institute (ICAR-IVRI)
• Indian Immunologicals Ltd.
• Laboratorios HIPRA SA (HIPRA)
• Merck Animal Health
• Phibro Animal Health Corporation
• Shandong Sinder Technology Co., Ltd.
• Vaxxinova International
• Vetoquinol S.A.
• Zoetis, Inc.;